维普中文期刊产品整合服务
17篇 您的检索式:作者名="Orsolini"
    题名 作者 年代 出处 被引量
1Projected Changes in Eurasian and Arctic Summer Cyclones under Global Warming in the Bergen Climate Model显示文摘Using the coupled ocean-atmosphere Bergen Climate Model,and a Lagrangian vorticity-based cyclone tracking method,the authors investigate current climate summer cyclones in the Northern Hemisphere and their change by the end of the 21st century,with a focus on Northern Eurasia and the Arctic.The two scenarios A1B and A2 for increasing greenhouse gas concentrations are considered.In the model projections,the total number of cyclones in the Northern Hemisphere is reduced by about 3% 4%,but the Arctic Ocean and adjacent coastal re-gions harbour slightly more and slightly stronger summer storms,compared to the model current climate.This in-crease occurs in conjunction with an increase in the high-latitude zonal winds and in the meridional tempera-ture gradient between the warming land and the ocean across Northern Eurasia.Deficiencies in climate model representations of the summer storm tracks at high lati-tudes are also outlined,and the need for further model inter-comparison studies is emphasized.Yvan J. ORSOLINI Asgeir SORTEBERG 2009Atmospheric and Oceanic Science Letters2009,2,1:2
2Regional evaluation of the post-salt system of Cabinda Angola显示文摘Bretthauer H Casimiro L Orsolini P 1998AAPG Bulletin1998,82,:1
3Modelling Capabilities Re- quired for the Double Nosing Process in the Assem- bly of Spherical Plain Bearings显示文摘Orsolini A Booker J D 2012Journal of Engi- neering Manufacture2012,226,5:1
4Efficient and chemoselective N-acylation of 10-amino-7-ethyl camptothecin with poly (ethylene glycol)显示文摘GUIOTTO A CANEVARI M ORSOLINI P 2004Bioorg Med Chem Lett2004,14,7:1
5Modelling Capabilities Required for the Double Nosing Process in the Assem- bly of Spherical Plain Bearings 显示文摘Alex Orsolini Julian D Booker 2012Journal of Engi- neering Manufacture2012,226,5:1
6PEG–Ara-C conjugates for controlled release显示文摘O Schiavon G Pasut S Moro P Orsolini A Guiotto F.M Veronese 2003European Journal of Medicinal Chemistry2003,,2:1
7Modeling Capabilities Required for the Double Nosing Process in the Assem- bly of Spherical Plain Bearings 显示文摘Alex Orsolini Julian D Booker 2012Journal of Engi- neering Manufacture2012,226,5:1
8Osteoporosis treat- ment: why ibandronic acid? 显示文摘Rossini M Orsolini G Adami S 2013Expert Opin Pharmacother2013,14,10:1
9Importance of the test medium for the release kinetics of a somatostatin analogue from poly ( D, L-lactic-co-glycolic acid ) microspheres 显示文摘Blanco-Prieto MJ Besseghir K Orsolini P 1999Int J Pharm1999,184,2:1
10Synthesis, characterization,and preliminary in vivo tests of new poly ( ethylene glycol) conjugates of the antitumor agent 10-Amino-7-ethylcamptothecin显示文摘GUIOTTO A CANEVARI M ORSOLINI P 2004J Med Chem2004,47,5:1
11Re- gional evaluation of the post-salt system of Cabinda Angola 显示文摘BRETTHAUER H CASIMIRO L ORSOLINI P 1998AAPG Bulletin1998,82,:1
12Role of Eurasian snow cover in wintertime circulation:Decadal simulations forced with satellite observations显示文摘Orsolini Y J Kvamsto N G 0,,1910:1
13Making Earthquakes Trembling 显示文摘Ravi Mathur Greg Orsolini Mark A Ketchum Tom Spoth 2002Roads & Bridges2002,40,5:1
14Modelling capabilities requircd for the double nosing process in the assembly of spherical plain bearings 显示文摘Alex Orsolini Julian D Booker 2012Journal of Engineering Manufacture2012,226,5:1
15Dual iso- tope imaging with LaBr3: Ce crystal and H8500 PSPMT 显示文摘Fabbfi A V Orsolini C Bennati V P 2013Journal of instrumentation2013,8,02:1
16Sety of eseitalopram in pregnancy : a case series显示文摘Beilantuono C Bozzi F Orsolini L 2013Neuropsychiatr Dis Treat2013,9,:1
17核医学在甲状腺良性疾病临床处治中的应用(第1部分):甲状腺功能亢进症显示文摘甲状腺良性疾病,尤其是甲状腺功能亢进症(简称甲亢)和甲状腺功能减退症(简称甲减),是最常见的内分泌疾病。甲亢常见的病因是自身免疫性甲亢(格雷夫斯病,即GD)、毒性多结节性甲状腺肿(TMNG)、毒性甲状腺腺瘤(TAs);其他少见病因包括破坏性甲状腺炎(胺碘酮导致的甲状腺功能异常)和人为甲亢。GD主要由促甲状腺激素受体抗体(TRAb)引起;TMNG和TAs由体细胞功能激活获得突变引起。甲亢患者典型的实验室表现为促甲状腺激素(TSH)降低,游离三碘甲状腺原氨酸(FT3)和游离甲状腺素(FT4)升高,以及GD患者TSH受体自身抗体升高。超声检查主要用于明确甲状腺大小、血供以及甲状腺结节的位置、大小、数目及影像特征。甲状腺超声和实验室检查是明确甲亢病因的一线诊断方法。甲状腺显像(^(131)I或99TcmO4-甲状腺显像)可用于鉴别不同类型的甲亢,为^(131)I治疗提供策略指导。甲状腺显像可帮助鉴别GD、TMNG、TAs和破坏性甲状腺炎。^(99)Tc^(m)O_(4)^(-)可鉴别胺碘酮导致的1型和2型甲亢。测定甲状腺摄碘率(RAIU)有助于明确甲亢^(131)I治疗的放射性活度。治疗甲亢的方案主要包括抗甲状腺药物(ATD)治疗、手术或^(131)I治疗。当患者ATD治疗失败、或有手术治疗禁忌或拒绝手术,可以考虑^(131)I治疗。对于TMNG或TAs患者,^(131)I治疗目的在于恢复正常甲状腺功能。对于GD患者,^(131)I治疗的目的在于诱发甲减,这种状态易通过口服甲状腺激素替代疗法治疗。可根据甲状腺大小和RAIU的计算剂量法指导^(131)I治疗的放射性活度。^(131)I治疗的早期毒性及不良反应(甲状腺床区轻微疼痛)可通过非甾体抗炎药来处理;晚期毒性及不良反应主要是甲减和辐射诱导的恶性肿瘤(发生率极低)。Giuliano Mariani Massimo Tonacchera Mariano Grosso Francesca Orsolini Paolo Vitti H.William Strauss 肖柳(译) 杨柳(译) 李林(审校) 2022中华核医学与分子影像杂志2022,42,10:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费